DocDollars

Ironwood Pharmaceuticals, Inc

MA · United States · Reporting entity ID 100000000245

Total reported 2019–2025
$49.2M
#176 of 2,960 reporting companies — 0.1% of all reported industry payments
$3.05M in general payments across 93,287 records, plus $46.1M in research funding across 6,114 records.

How it breaks down

General payments $3,053,785
Research funding $46,126,273

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ironwood Pharmaceuticals, Inc reported $49.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #176 of 2,960 reporting companies. 94% of that was research funding and 6% general payments such as consulting, speaking, food and travel. 93,287 general payment records and 6,114 research records were filed.

Common questions about Ironwood Pharmaceuticals, Inc

How much has Ironwood Pharmaceuticals, Inc paid US doctors?

Ironwood Pharmaceuticals, Inc reported $49,180,058 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $3,053,785 in general payments, $46,126,273 in research funding.

How does Ironwood Pharmaceuticals, Inc rank among drug and device companies?

It ranks #176 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Ironwood Pharmaceuticals, Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.